Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

EDAP TMS S.A. (EDAP)

  • SEC News
  • Jan. 14, 2026, 21:07 UTC
  • 4
  • 0 comments

New Form 3 - EDAP TMS SA Filed: 2026-01-14 AccNo: 0001829126-26-000301 Size: 18 KB

Comment Full text

Clearpoint Neuro Inc (CLPT)

  • SEC News
  • Jan. 14, 2026, 21:07 UTC
  • 4
  • 0 comments

New Form S-3 - ClearPoint Neuro, Inc. Filed: 2026-01-14 AccNo: 0001683168-26-000309 Size: 559 KB

Comment Full text

EDAP TMS S.A. (EDAP)

  • SEC News
  • Jan. 14, 2026, 21:07 UTC
  • 3
  • 0 comments

New Form 3 - EDAP TMS SA Filed: 2026-01-14 AccNo: 0001829126-26-000302 Size: 15 KB

Comment Full text

BiomX Inc. (PHGE)

  • SEC News
  • Jan. 14, 2026, 21:05 UTC
  • 0
  • 1 comments

(99% Neutral) BiomX Inc. (PHGE) Announces New Board Appointment

Comment Full text

Safety Shot Inc (SHOT)

  • SEC News
  • Jan. 14, 2026, 20:46 UTC
  • 0
  • 1 comments

(99% Neutral) Safety Shot Inc (SHOT) Announces New Board Appointment

Comment Full text

PetVivo Holdings Inc. (PETV)

  • SEC News
  • Jan. 14, 2026, 18:01 UTC
  • 0
  • 1 comments

(99% Neutral) PetVivo Holdings Inc. (PETV) Announces Executive Departure

Comment Full text

AgeX Therapeutics Inc. (was merged with Biotechnology Serina Therapeutics (NYSE: SER) on 27/04/2024) (AGE)

  • SEC News
  • Jan. 14, 2026, 17:56 UTC
  • 0
  • 1 comments

Moreadith Randall 🟡 adjusted position in 6.5K shares (2 derivative) of Serina Therapeutics, Inc. (SER) at $2.50 Transaction Date: Jan 13, 2026 | Filing ID: 000004

Comment Full text

Quanterix Corp (QTRX)

  • SEC News
  • Jan. 14, 2026, 16:01 UTC
  • 0
  • 1 comments

Elliott Jeffrey Thomas 🟢 acquired 23.4K shares of Quanterix Corp (QTRX) Transaction Date: Jan 02, 2026 | Filing ID: 000001

Comment Full text

Mesoblast Ltd. (MEOBF)

  • SEC News
  • Jan. 14, 2026, 15:57 UTC
  • 8
  • 0 comments

New Form 424B3 - MESOBLAST LTD Filed: 2026-01-14 AccNo: 0001213900-26-004248 Size: 327 KB

Comment Full text

Sigyn Therapeutics Inc. (SIGY)

  • SEC News
  • Jan. 14, 2026, 14:11 UTC
  • 6
  • 0 comments

New Form SCHEDULE 13G/A - Sigyn Therapeutics, Inc. Filed: 2026-01-14 AccNo: 0001213900-26-004186 Size: 11 KB

Comment Full text
  • Previous
  • 131
  • 132
  • 133
  • 134
  • 135
  • Next

Search

News categories

  • Technical Exchange News(10870)
  • Event(2243)
  • SEC News(189155)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124506)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin